This website uses cookies for functional and analytical purposes. Please click 'accept' to to keep browsing.

  • Our platform
  • Careers
  • About
  • News
  • Contact
Contacts
  • San Francisco, US
  • T: +4686111212
  • E: info@enginzyme.com
  • Stockholm, Sweden
  • T: +46-8-6111212
  • E: info@enginzyme.com

News

Stay up to date with our latest news

Explore
decoration

Latest press releases

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

EnginZyme AB, a deep-tech company whose cell-free biomanufacturing technology...

Oct 25, 2023

EnginZyme News

Five questions on pseudouridine, with Matthew Thompson

Press releases are necessarily short, so we like to go...

Oct 25, 2023

More news

All Article Blog Pressrelease

Five questions on pseudouridine, with Matthew Thompson

Oct 25, 2023

Blog

Read more about pseudouridine and mRNA

Oct 25, 2023

Blog

White Paper: Avoiding critical nucleoside impurities in Beta-Pseudouridine: A Technical Insight

Oct 25, 2023

Blog

EnginZyme produces key mRNA vaccine ingredient using biocatalysis

Oct 25, 2023

Pressrelease

How Artificial Intelligence is pushing biobased chemistry forward

Aug 09, 2023

Blog

EnginZyme pitches cell-free biomanufacturing platform at P&G Fabric and Home Care event

Mar 27, 2023

Blog

1 2 3 … 7

Media contact

image description

Karim Engelmark Cassimjee

CEO and co-founder
  • press@enginzyme.com

Media kit

  • Download images
  • Download presskit

Stay in touch with us.
Sign up here for EnginZyme Insights.

Thanks for signing up!

Please check your email inbox to confirm.

Could not submit form.

Please check for errors.

© 2014 – 2025 EnginZyme AB

About
  • About EnginZyme
  • Careers
  • Contact us
Products and services
  • Our platform
Contact
  • E: info@enginzyme.com
  • Tomtebodavägen 6
  • 171 65 Solna, Sweden